Evidence map›Paper›PMID 40108432›Full record

ArticleScientific reports2025

Artificial intelligence to enhance the diagnosis of ocular surface squamous neoplasia.

Kincső Kozma, Zoltán Richárd Jánki, Vilmos Bilicki, Adrienne Csutak, Eszter Szalai

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Enhanced Imaging of Ocular Surface Lesions.Journal of clinical medicine · 2025
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kincső KozmaDepartment of Ophthalmology, Medical School, University of Pécs, Rákóczi u. 2, Pecs, 7623, Hungary.
Zoltán Richárd JánkiDepartment of Software Engineering, University of Szeged, Dugonics tér 13, Szeged, 6720, Hungary.
Vilmos BilickiDepartment of Software Engineering, University of Szeged, Dugonics tér 13, Szeged, 6720, Hungary.
Adrienne CsutakDepartment of Ophthalmology, Medical School, University of Pécs, Rákóczi u. 2, Pecs, 7623, Hungary.
Eszter SzalaiDepartment of Ophthalmology, Medical School, University of Pécs, Rákóczi u. 2, Pecs, 7623, Hungary. szalai.eszter@pte.hu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To provide an artificial intelligence (AI) method using in vivo confocal microscopy (IVCM) to differentiate ocular surface squamous neoplasia (OSSN) from other lesions and compare the performance of well-known AI-related solutions. A dataset of 2,774 IVCM images, comprising OSSN and other ocular surface diseases was used to train three deep learning models: ResNet50V2, Yolov8x, and VGG19. These models were trained to identify OSSN-related lesions by recognizing specific visual features, including the "starry-sky" pattern, hyperkeratosis, mitotic figures and irregularly shaped epithelial cells. To mitigate class imbalance, a novel square-based data augmentation strategy was employed. Additionally, we implemented a few-shot learning model to enhance the precision of rare symptoms, such as mitosis. To enhance model interpretation, Shapley values and Uniform Manifold Approximation and Projection (UMAP) analysis were employed to explain decision-making processes. The AI models demonstrated high accuracy in distinguishing healthy tissues from pathological ones, achieving over 90% accuracy across all models. In our binary classification task, all AI models had accuracy above 97% (precision ≥ 98%, recall ≥ 85%, F1 score ≥ 92%). The model achieved lower accuracy in 4 class labeled classification. Aggregation of cell-level results provided the best performance with an F1 score of 100%. The models successfully identified patient-specific features in IVCM images, suggesting that these images can act as "fingerprints". Our AI model utilizing IVCM was able to classify OSSN with high accuracy. Moreover, cell-level classification results could be backpropagated to image-level and patient-level. The patient-specific information within IVCM images offers promise for personalized diagnostics and treatment monitoring in ocular oncology.

Indexed as

Artificial IntelligenceCarcinoma, Squamous CellEye NeoplasmsDeep LearningHumansMicroscopy, ConfocalArtificial intelligenceIn vivo confocal microscopyNeural networkOcular oncologyOcular surface squamous neoplasia

Identifiers

PMID40108432
PMCPMC11923146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.